Brand Recall Hub

Finds Recalls in Canada

5 recalls found for Finds. Data sourced from Health Canada, CFIA, and Transport Canada. Updated daily.

5 Finds Recalls

Other
2022-01-12

Health Canada safety review finds link between the use of Xeljanz and Xeljanz XR (tofacitinib) and increased risk of serious heart-related issues and cancer

Product safety

View recall details →
Other
2019-05-08

Testing finds pharmaceutical ingredients in unauthorized health products seized from Sunrise Lee Chinese Herbs Centre in Calgary, Alberta

Unauthorized product - Product safety

View recall details →
Other
2019-03-15

Clinical trial finds an increased risk of blood clots in the lungs and of death in rheumatoid arthritis patients taking high dose of tofacitinib (sold as Xeljanz or Xeljanz XR)

Product safety

View recall details →
Other
2019-01-11

Health Canada safety review finds possible link between Fibristal and risk of liver injury

View recall details →
Other
2018-10-02

Health Canada finds Zhejiang Huahai Pharmaceuticals site non-compliant with requirements for the manufacture of drug ingredients

View recall details →